SCHEMBL1992389

SCHEMBL1992389

O=C1NC(=O)C(c2c[nH]c3sccc23)=C1c1nc(Cl)nc2sccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 19/20 0.38
PRKCA P17252 18/20 0.38
PRKCH P24723 18/20 0.38
PRKCD Q05655 18/20 0.38
PRKCB P05771 17/20 0.38
PRKCE Q02156 16/20 0.38
PIM1 P11309 4/20 0.38
PRKACA P17612 4/20 0.38
PRKD3 O94806 3/20 0.38
CDK2 P24941 3/20 0.38
ABL1 P00519 3/20 0.38
PRKCG P05129 2/20 0.38
CDK1 P06493 2/20 0.38
PRKCI P41743 2/20 0.38
PRKCZ Q05513 2/20 0.38
CAMK2D Q13557 2/20 0.38
CCNE2 O96020 2/20 0.38
CDK4 P11802 2/20 0.38
PRKACG P22612 2/20 0.38
PRKACB P22694 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1992220 0.86 PRKCH (0.48) PRKCQPRKCAPRKCHPRKCDPRKCB
SCHEMBL1991614 0.79 PRKCH (0.57) PRKCQPRKCAPRKCHPRKCDPRKCB
SCHEMBL1990079 0.79 PRKCH (0.59) PRKCQPRKCAPRKCHPRKCDPRKCB
SCHEMBL1993950 0.76 PRKCH (0.49) PRKCQPRKCAPRKCHPRKCDPRKCB
SCHEMBL1993007 0.75 PRKCH (0.45) PRKCQPRKCAPRKCHPRKCDPRKCB
SCHEMBL1992998 0.73 PRKCH (0.42) PRKCQPRKCAPRKCHPRKCDPRKCB
SCHEMBL1993004 0.73 PRKCH (0.42) PRKCQPRKCAPRKCHPRKCDPRKCB
SCHEMBL1996741 0.70 PRKCH (0.75) PRKCQPRKCAPRKCHPRKCDPRKCB
SCHEMBL1991636 0.70 PRKCH (0.48) PRKCQPRKCAPRKCHPRKCDPRKCB
SCHEMBL1997849 0.69 PRKCH (0.74) PRKCQPRKCAPRKCHPRKCDPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKCQ 3598/4885PRKCA 3438/4885PRKCH 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.